Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma
- Author
- LOPES DE MENEZES, Daniel E1 ; DENIS-MIZE, Kimberly1 ; WILSON, Susan E1 ; JALLAL, Bahija1 ; AUKERMAN, Sharon L1 ; YAN TANG1 ; YE, Helen1 ; KUNICH, John C1 ; GARRETT, Evelyn N1 ; JING PENG1 ; COUSENS, Lawrence S1 ; GELB, Arnold B1 ; HEISE, Carla1
[1] Chiron Corporation, Biopharma Research and Development, Emeryville, CA, United States - Source
Journal of immunotherapy (1997). 2007, Vol 30, Num 1, pp 64-74, 11 p ; ref : 47 ref
- CODEN
- JOIMF8
- ISSN
- 1524-9557
- Scientific domain
- Pharmacology drugs
- Publisher
- Lippincott, Hagerstown, MD
/
Lippincott, Philadelphia,PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- Proleukin immunotherapy interleukin-2 non-Hodgkin lymphoma rituximab
- Keyword (fr)
- Activité biologique Animal Anticorps monoclonal Homme Immunodépresseur Immunomodulateur Immunothérapie Interleukine 2 Lymphocyte B Lymphome non hodgkinien Protéine recombinante Rituximab Traitement Tumeur maligne Antigène CD20 Anticytokine Cytokine Hémopathie maligne Lymphoprolifératif syndrome
- Keyword (en)
- Biological activity Animal Monoclonal antibody Human Immunosuppressive agent Immunomodulator Immunotherapy Interleukin 2 B-Lymphocyte Non Hodgkin lymphoma Recombinant protein Rituximab Treatment Malignant tumor Anticytokine Cytokine Malignant hemopathy Lymphoproliferative syndrome
- Keyword (es)
- Actividad biológica Animal Anticuerpo monoclonal Hombre Inmunodepresor Inmunomodulador Inmunoterapia Interleuquina 2 Linfocito B Linfoma no Hodgkin Proteína recombinante Rituximab Tratamiento Tumor maligno Anticitoquina Citoquina Hemopatía maligna Linfoproliferativo síndrome
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R03 Immunotherapy
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18396533
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/01.cji.0000211315.21116.07 
https://dx.doi.org/10.1097/01.cji.0000211315.21116.07
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.cji.0000211315.21116.07\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Journal of immunotherapy (1997)\";s:9:\"\u0000*\u0000stitle\";s:21:\"J. immunother. (1997)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"64\";s:8:\"\u0000*\u0000epage\";s:2:\"74\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1524-9557\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"LOPES DE MENEZES\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Daniel E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:20:\"DENIS-MIZE, Kimberly\";i:1;s:15:\"WILSON, Susan E\";i:2;s:14:\"JALLAL, Bahija\";i:3;s:18:\"AUKERMAN, Sharon L\";i:4;s:8:\"YAN TANG\";i:5;s:9:\"YE, Helen\";i:6;s:14:\"KUNICH, John C\";i:7;s:17:\"GARRETT, Evelyn N\";i:8;s:9:\"JING PENG\";i:9;s:19:\"COUSENS, Lawrence S\";i:10;s:14:\"GELB, Arnold B\";i:11;s:12:\"HEISE, Carla\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOIMF8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:133:\"Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:10:\"Lippincott\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.cji.0000211315.21116.07\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Journal of immunotherapy (1997)\";s:9:\"\u0000*\u0000stitle\";s:21:\"J. immunother. (1997)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"64\";s:8:\"\u0000*\u0000epage\";s:2:\"74\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1524-9557\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"LOPES DE MENEZES\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Daniel E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:20:\"DENIS-MIZE, Kimberly\";i:1;s:15:\"WILSON, Susan E\";i:2;s:14:\"JALLAL, Bahija\";i:3;s:18:\"AUKERMAN, Sharon L\";i:4;s:8:\"YAN TANG\";i:5;s:9:\"YE, Helen\";i:6;s:14:\"KUNICH, John C\";i:7;s:17:\"GARRETT, Evelyn N\";i:8;s:9:\"JING PENG\";i:9;s:19:\"COUSENS, Lawrence S\";i:10;s:14:\"GELB, Arnold B\";i:11;s:12:\"HEISE, Carla\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOIMF8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:133:\"Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:10:\"Lippincott\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.cji.0000211315.21116.07\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.cji.0000211315.21116.07\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Journal of immunotherapy (1997)\";s:9:\"\u0000*\u0000stitle\";s:21:\"J. immunother. (1997)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"64\";s:8:\"\u0000*\u0000epage\";s:2:\"74\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1524-9557\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"LOPES DE MENEZES\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Daniel E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:20:\"DENIS-MIZE, Kimberly\";i:1;s:15:\"WILSON, Susan E\";i:2;s:14:\"JALLAL, Bahija\";i:3;s:18:\"AUKERMAN, Sharon L\";i:4;s:8:\"YAN TANG\";i:5;s:9:\"YE, Helen\";i:6;s:14:\"KUNICH, John C\";i:7;s:17:\"GARRETT, Evelyn N\";i:8;s:9:\"JING PENG\";i:9;s:19:\"COUSENS, Lawrence S\";i:10;s:14:\"GELB, Arnold B\";i:11;s:12:\"HEISE, Carla\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOIMF8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:133:\"Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:10:\"Lippincott\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.cji.0000211315.21116.07\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Journal of immunotherapy (1997)\";s:9:\"\u0000*\u0000stitle\";s:21:\"J. immunother. (1997)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"64\";s:8:\"\u0000*\u0000epage\";s:2:\"74\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1524-9557\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"LOPES DE MENEZES\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Daniel E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:20:\"DENIS-MIZE, Kimberly\";i:1;s:15:\"WILSON, Susan E\";i:2;s:14:\"JALLAL, Bahija\";i:3;s:18:\"AUKERMAN, Sharon L\";i:4;s:8:\"YAN TANG\";i:5;s:9:\"YE, Helen\";i:6;s:14:\"KUNICH, John C\";i:7;s:17:\"GARRETT, Evelyn N\";i:8;s:9:\"JING PENG\";i:9;s:19:\"COUSENS, Lawrence S\";i:10;s:14:\"GELB, Arnold B\";i:11;s:12:\"HEISE, Carla\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOIMF8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:133:\"Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:10:\"Lippincott\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1097\/01.cji.0000211315.21116.07\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:133:\"Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Journal of immunotherapy (1997)\";s:9:\"\u0000*\u0000stitle\";s:21:\"J. immunother. (1997)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"64\";s:8:\"\u0000*\u0000epage\";s:2:\"74\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1524-9557\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:16:\"LOPES DE MENEZES\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Daniel E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:12:{i:0;s:20:\"DENIS-MIZE, Kimberly\";i:1;s:15:\"WILSON, Susan E\";i:2;s:14:\"JALLAL, Bahija\";i:3;s:18:\"AUKERMAN, Sharon L\";i:4;s:8:\"YAN TANG\";i:5;s:9:\"YE, Helen\";i:6;s:14:\"KUNICH, John C\";i:7;s:17:\"GARRETT, Evelyn N\";i:8;s:9:\"JING PENG\";i:9;s:19:\"COUSENS, Lawrence S\";i:10;s:14:\"GELB, Arnold B\";i:11;s:12:\"HEISE, Carla\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOIMF8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:133:\"Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-hodgkin lymphoma\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:10:\"Lippincott\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
